COBRA PzF™ nanocoated coronary stents study

There have been significant advancements in the development of stents that have prevented stenosis in coronary arteries. Drug-eluting stents reduced in-stent restenosis and have shown better outcomes compared with bare-metal stents with some limitations. The COBRA PzF nanocoated coronary stent has been associated with accelerated endothelialization relative to drug-eluting stents, reduced inflammation, and thromboresistance which suggest a more flexible dual antiplatelet therapy requirement with potential benefits especially in those at high bleeding risk in preclinical studies.

Check out the recently published article, a study led by Dr. Anne Cornelissen, in Future Cardiology, indicating the significance of COBRA PzF nanocoated coronary stents.